Combination of omics, bioinformatics, molecular docking, and experimental validation to elucidate the hepatoprotective effects, mechanisms, and active compounds of Shandougen
Authors:
- 15 May 2024
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 38 (7) , e5887
Abstract
Omics, bioinformatics, molecular docking, and experimental validation were used to elucidate the hepatoprotective effects, mechanisms, and active compounds of Shandougen (SDG) based on the biolabel‐led research pattern. Integrated omics were used to explore the biolabels of SDG intervention in liver tissue. Subsequently, bioinformatics and molecular docking were applied to topologically analyze its therapeutic effects, mechanisms, and active compounds based on biolabels. Finally, an animal model was used to verify the biolabel analysis results. Omics, bioinformatics, and molecular docking revealed that SDG may exert therapeutic effects on liver diseases in the multicompound and multitarget synergistic modes, especially liver cirrhosis. In the validation experiment, SDG and its active compounds (betulinic acid and gallic acid) significantly improved the liver histopathological damage in the CCl4‐induced liver cirrhosis model. Meanwhile, they also produced significant inhibitory effects on the focal adhesion pathway (integrin alpha‐1, myosin regulatory light chain 2, laminin subunit gamma‐1, etc.) and alleviated the associated pathological processes: focal adhesion (focal adhesion kinase 1)–extracellular matrix (collagen alpha‐1(IV) chain, collagen alpha‐1(VI) chain, and collagen alpha‐2(VI) chain) dysfunction, carcinogenesis (alpha‐fetoprotein, NH3, and acetylcholinesterase), inflammation (tumor necrosis factor alpha, interleukin‐1 [IL‐1], IL‐6, and IL‐10), and oxidative stress (reactive oxygen species, malonaldehyde, and superoxide dismutase). This study provides new evidence and insights for the hepatoprotective effects, mechanisms, and active compounds of SDG.Keywords
Funding Information
- National Natural Science Foundation of China (81960749)
This publication has 27 references indexed in Scilit:
- Biolabel‐led research pattern reveals serum profile in rats after treatment with Herba Lysimachiae: Combined analysis of metabonomics and proteomicsBiomedical Chromatography, 2022
- Biolabel-led research pattern positions the effects and mechanisms of Sophorae Tonkinensis radix et rhizome on lung diseases: A novel strategy for computer-aided herbal medicine research based on omics and bioinformaticsComputers in Biology and Medicine, 2021
- A biolabel research based on metabonomics reveals the therapeutic potentials of Herba Lysimachiae in synovial diseases: The dual effects on synovial platelet aggregation by prostaglandin E1/E2Journal of Chromatography B, 2021
- Label-free quantitative proteomics positions the effects and mechanisms of Herba Lysimachiae on synovial diseases based on biolabel-led research patternJournal of Chromatography B, 2020
- Drug-likeness prediction of chemical constituents isolated from Chinese materia medica CiwujiaJournal of Ethnopharmacology, 2017
- A review on phytochemistry and pharmacological activities of the processed lateral root of Aconitum carmichaelii DebeauxJournal of Ethnopharmacology, 2015
- Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosisJournal of Hepatology, 2011
- Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinomaHuman Pathology, 2009
- Changes in liver and plasma acetylcholinesterase in rats with cirrhosis induced by bile duct ligationHepatology, 2006
- Control of motile and invasive cell phenotypes by focal adhesion kinaseBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2004